Home › Funds › LINDEN ADVISORS LP › IPCX
LINDEN ADVISORS LP position in IPCX
ROIVANT SCIENCES LTD
LINDEN ADVISORS LP reported holding 1,865,000 shares of IPCX (ROIVANT SCIENCES LTD) in its Q2 2026 13F filing — a position valued at US$19.2M, representing 0.83% of its reported portfolio and ranking #6 among its reported holdings. LINDEN ADVISORS LP has disclosed IPCX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How LINDEN ADVISORS LP's IPCX position evolved
LINDEN ADVISORS LP first disclosed a stake in IPCX in Q2 2025 at 1,590,000 shares (US$16.3M). The position peaked in Q2 2026 at 1,865,000 shares, worth US$19.2M. Across 5 filings, LINDEN ADVISORS LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 1,865,000 shares valued at US$19.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 1.59M | $16.30M | New |
| Q3 2025 | 1.86M | $18.82M | Add |
| Q4 2025 | 1.86M | $18.91M | Hold |
| Q1 2026 | 1.86M | $19.04M | Hold |
| Q2 2026 | 1.86M | $19.25M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IPCX and 13F data
IPCX (ROIVANT SCIENCES LTD) is a company whose sector is not yet classified in our data. 60 other funds we track also report a position in IPCX — the largest reported positions include BERKLEY W R CORP (US$22.8M), RLH Capital LLC (US$14.7M), MMCAP International Inc. SPC (US$14.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IPCX
- BERKLEY W R CORP 2.21M sh · $22.82M · Q2 2026
- RLH Capital LLC 1.42M sh · $14.72M · Q2 2026
- MMCAP International Inc. SPC 1.40M sh · $14.46M · Q2 2026
- Crossingbridge Advisors, LLC 1.24M sh · $12.77M · Q2 2026
- RiverPark Advisors, LLC 960.94K sh · $9.92M · Q2 2026
- Quarry LP 907.56K sh · $9.38M · Q2 2026
- Mercuria Capital Strategies, LLC 535.00K sh · $5.53M · Q2 2026
- Wealthspring Capital LLC 511.52K sh · $5.28M · Q2 2026
- Mint Tower Capital Management B.V. 450.00K sh · $4.65M · Q2 2026
- SkyView Investment Advisors, LLC 153.31K sh · $1.58M · Q2 2026
More on LINDEN ADVISORS LP
FAQ
How long has LINDEN ADVISORS LP held IPCX?
LINDEN ADVISORS LP has disclosed IPCX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is LINDEN ADVISORS LP's current position in IPCX?
As of Q2 2026, LINDEN ADVISORS LP holds 1.86M shares of IPCX (ROIVANT SCIENCES LTD), valued at $19.25M, representing 0.83% of its reported portfolio and ranking #6.
Has LINDEN ADVISORS LP been buying or selling IPCX?
In the latest 13F filing (Q2 2026), LINDEN ADVISORS LP held unchanged its position in IPCX. The position peaked in Q2 2026 at 1.86M shares.
Which other funds hold IPCX?
Other major institutional holders of IPCX include BERKLEY W R CORP, RLH Capital LLC, MMCAP International Inc. SPC, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.